Results of a UK survey on methods for compensating for unscheduled treatment interruptions and errors in treatment delivery

British Journal of Radiology

Volumn 80, Issue 953, 2007, Pages 367-370

  Dale, R G ^a,b,d   Jones, B ^c   Sinclair, J A ^a   Comins, C ^a   Antoniou, E ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; HEALTH CARE DELIVERY; HUMAN; MEDICAL EDUCATION; QUESTIONNAIRE; RADIATION HAZARD; RADIOBIOLOGY; RADIOLOGIST; RADIOTHERAPY; STANDARDIZATION; THERAPEUTIC ERROR; UNITED KINGDOM;

CLINICAL PROTOCOLS; GREAT BRITAIN; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HUMANS; MEDICAL ERRORS; NEOPLASMS; QUESTIONNAIRES; RADIOLOGY DEPARTMENT, HOSPITAL;

EID: 34548233245     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/53036313     Document Type: Article

References (8)

1. Royal College of Radiologists. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy, 2nd edn. London: The Royal College of Radiologists, 2002.
2. Hendry JH, Bentzen SM, Dale RG, Fowler JF, Wheldon TE, Jones B, et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol 1996;8:297-307.
3. Dale RG, Hendry JH, Jones B, Robertson AG, Deehan C, Sinclair JA. Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules. Clin Oncol 2002;14:382-93.
4. Roberts SA, Hendry JA. The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-related datasets. Radiother Oncol 1993;29:69-74.
5. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
6. Bentzen SM, Heeren G, Cottier B, Slotman B, Glimelius B, Lievens Y, et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 2005;75:355-65.
7. Dale RG, Jones B. Mathematical modelling and its applications in radiation oncology. In: Price P, Sikora K, editors. Treatment of cancer, 4th edn. London: Arnold, 2006:67-80.
8. Jones B, Dale, RG, Deehan C, Hopkins KI, Morgan DA. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol 2001;13:71-81.